Evidence map›Paper›PMID 42458379›Full record

ArticleBMC endocrine disorders2026

Escalating diabetes prevalence in pakistan: a qualitative study of endocrinologists' perspectives on contributing factors, management barriers, and strategies.

Muhammad Ebad Khan, Matti Ullah, Muhammad Usman Khan, Malaika Nasir, Irum Khan, Nayab Tariq, Owais Qarni, Zainab Ishtiaq, Azra Batool, Mahnoor Ajmal and 4 more

Abstract read
In one paragraph

Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Muhammad Ebad KhanDepartment of Pharmacy Practice, Faculty of Pharmacy, Hamdard University Islamabad Campus, Islamabad, Pakistan. m.ebad0316@gmail.com.ORCID http://orcid.org/0009-0006-8675-6520
Matti UllahDepartment of Pharmacy Practice, Faculty of Pharmacy, Hamdard University Islamabad Campus, Islamabad, Pakistan.
Muhammad Usman KhanDepartment of Pharmacy, Islamabad, H-9 Campus, Pakistan. m.usman0341@gmail.com.
Malaika NasirDepartment of Pharmacy, Islamabad, H-9 Campus, Pakistan.
Irum KhanDepartment of Pharmacy, Islamabad, H-9 Campus, Pakistan.
Nayab TariqDepartment of Pharmacy, Islamabad, H-9 Campus, Pakistan.
Owais QarniDepartment of Pharmacy, Islamabad, H-9 Campus, Pakistan.
Zainab IshtiaqDepartment of Pharmacy Practice, Faculty of Pharmacy, Hamdard University Islamabad Campus, Islamabad, Pakistan.
Azra BatoolDepartment of Pharmacy, Faculty of Pharmacy, Hamdard University Islamabad Campus, Islamabad, Pakistan.
Mahnoor AjmalDepartment of Pharmacy, Faculty of Pharmacy, Hamdard University Islamabad Campus, Islamabad, Pakistan.
Aqsa AbbasiDepartment of Pharmacy, Chak Shahzad Campus, Islamabad, Pakistan.
Alishba BibiCollege of Nursing, G-7-3-4, Islamabad, Pakistan.
Tanveer Afsar MalikFederal Government Polyclinic Hospital, Islamabad, Pakistan.
Sidra HafeezDepartment of Pharmacy, Faculty of Pharmacy, Hamdard University Islamabad Campus, Islamabad, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPakistan has one of the highest diabetes prevalence rates globally, yet limited research exists on endocrinologists' perspectives regarding drivers, barriers, and solutions.

methodsThis qualitative study conducted semi-structured interviews with 21 endocrinologists across Islamabad, Rawalpindi, and Peshawar from March to April 2026. Purposive sampling was used to recruit participants. Inductive thematic analysis following Braun & Clarke's framework identified four main themes and nineteen subthemes.

resultsEndocrinologists perceived a drastic rise in diabetes prevalence, with most estimating that one in three adults is now affected (based on their clinical observations) and reported a 50% increase in cases over 2-3 years and early onset type 2 diabetes in patients as young as 17-20 years. Urban-rural disparities were evident: urban areas have higher prevalence driven by sedentary lifestyles and unhealthy diets, while rural populations present with advanced disease and limited access to care. Factors contributing to diabetes prevalence included unhealthy dietary habits, sedentary lifestyle, obesity (with one participant estimating 52% central obesity), genetic predisposition, and stress/sleep disturbances. Major barriers comprised poor treatment adherence, financial constraints (insulin unaffordable for many), low health literacy (with most participants estimating approximately 98% of patients lacking basic knowledge), cultural misconceptions (insulin phobia, traditional remedies), medication shortages, and healthcare system limitations (2-3 min per patient). Strategies identified were patient education (with one participant estimating 80% of disease management), early screening, primordial prevention from childhood, government support for affordable medications, and the pharmacist as an underutilized diabetes educator.

conclusionPakistan faces an accelerating diabetes epidemic with a concerning shift to younger populations. Multi-level interventions addressing financial barriers, health literacy, cultural beliefs, systemic constraints, and expanding the pharmacist's role as educator are urgently needed. CLINICAL

trial registrationNot applicable.

Indexed as

Attitude of Health PersonnelDiabetes Mellitus, Type 2EndocrinologistsHealth Services AccessibilityAdultFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedPakistanPrevalenceQualitative ResearchRisk FactorsBarriers to careDiabetes prevalenceEndocrinologistsPakistanPatient educationPharmacist roleQualitative study

Identifiers

PMID42458379
PMCPMC13656454

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.